Expand CHRS Menu
CHRS MENU

Coherus Oncology (CHRS)'s 30-day implied volatility (IV30) was 93.6% at the close on November 17, 2026, up from 91.8% the day before, against a 52-week range of 51.5% to 180.0%. Its 20-day historical volatility was 105.8%.

Key numbers
  • 30-day implied volatility (IV30): 93.6%
  • IV30 52-week range: 51.5% to 180.0% (median 81.5%)
  • Historical volatility: 20-day 105.8%, 1-year 81.5%
  • Implied move by the nearest expiration: ±5.0%

Data as of November 17, 2026.

CHRS Implied Volatility (IV) vs Historical Volatility (HV)

Market Data Delayed 15 Minutes